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ORIGINAL ARTICLE
Background/Aims: Antibiotic skin testing is a useful procedure for identifying patients with IgE-mediated
hypersensitivity to antibiotics. The procedures, however, have not been standardized, and the testing is
performed with diverse protocols in Korean hospitals wards. Thus, we examined the current practice of antibiotic
skin testing in Korea.
Methods: We sent questionnaires to 12 allergists working in secondary or tertiary referral hospitals and collected
them by e-mail or fax. The questionnaire included items such as the types and concentrations of the tested antibiotics,
the methods of antibiotic skin testing, and the interpretation of the results.  
Results: All hospitals responded to the questionnaire. The antibiotic skin testing protocols were variable,
inconsistent, and differed with regard to the type and concentrations of antibiotics, the volume injected, and the
interpretation of the results. Moreover, the protocols differed from the commonly recommended procedures in the
medical literature. 
Conclusions: Standardized guidelines for antibiotic skin testing are needed for the safe and effective use of
antibiotics in Korea. (Korean J Intern Med 2010;25:207-212)
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INTRODUCTION
Adverse reactions to antibiotic drugs are common, and
up to 25% of patients who are treated with antimicrobial
agents report allergic reactions to antimicrobials [1].
Penicillin is the most frequently implicated agent;
approximately 10% to 20% of hospitalized patients have
a history of penicillin allergy [1,2]. As the use of semi-
synthetic penicillins (amoxicillin and ampicillin) and
cephalosporins has increased, these agents are becoming
a major cause of allergic responses [3]. Generally, non-
beta-lactam antibiotics such as vancomycin and
fluoroquinolones are commonly used in patients with a
history of beta-lactam allergy to avoid allergic reactions.
The use of alternative antibiotics is associated with an
increased number of infections caused by multidrug-
resistant bacterial strains, which is associated with higher
costs for care, morbidity, and mortality [4-7]. To solve this
problem, identifying patients in the clinical setting who
are at high risk for immediate IgE-mediated reactions is
essential. Antibiotic skin testing (AST) is well-known to be
a safe and reliable method for detecting immediate
allergic reactions to beta-lactams. Although skin testing
is a routine antibiotic test in Korean hospital wards,
methods vary from hospital to hospital. The purpose of
this study was to examine the current practice of AST in
Korea.METHODS
We selected 12 hospitals that employed allergy specialists.
To represent general practices in Korea, we tried to avoid
deviations in grade and location of the hospitals, so three
secondary hospitals (J to L, Table 1) and nine tertiary
hospitals (A to I, Table 1) were enrolled. Among them, one
secondary hospital (J, Table 1) and five tertiary hospitals
(C to G, Table 1) were located in Seoul, and two secondary
hospitals (K and L, Table 1) and four tertiary hospitals
(A, B, H, and I, Table 1) were located in the province.
Questionnaires were sent to the allergists, and the responses
were collected either by e-mail or fax. The questionnaire
included items such as the type and concentration of the
antibiotics tested, the testing methods, and the inter-
pretation of the test results. The questions were as follows:
1) Do you routinely conduct AST before using antibiotics
in your wards? If so, how many and which antibiotics do
you test? 2) Clarify the details of the methods for AST, e.g.,
testing method (skin prick testing vs. intradermal testing),
concentrations and doses of antibiotics tested, test site,
and whether a control substance is tested. 3) Clarify the
method for AST interpretation, e.g., time lag between
testing and interpretation and criteria for positivity. 
RESULTS
The response rate was 100%. In all hospitals, the AST
was a routine procedure before starting certain antibiotics
in general wards and was usually conducted by a nurse
without regard to allergic reaction history. However, the
number of antibiotics tested varied from three to five.
Among 12 hospitals, the ASTs for penicillins and
cephalosporins were performed in 10 and 11 hospitals,
respectively. In one hospital (E, Table 1), ASTs for
cephalosporins were not routinely performed based on the
idea that no study has demonstrated the clinical utility of
cephalosporin skin testing for screening in subjects
without a drug allergy history. Moreover, in two hospitals
(H and I, Table 1), ASTs for penicillins were not performed
because penicillins were never prescribed in these hospitals
for fear of an adverse reaction. For other beta-lactam
antibiotics, semisynthetic penicillins such as ampicillin
and amoxicillin were tested in eight hospitals, carbapenems
such as imipenem and meropenem in nine hospitals, and
monobactams such as aztreonam in one hospital.
Additionally, ASTs for vancomycin were conducted in four
hospitals, and ASTs for aminoglycosides such as
streptomycin were carried out in three hospitals. The
details are shown in Table 1. Antibiotics other than those
listed above were used without prior skin tests in all
hospitals. 
The ASTs were performed on the volar forearm using
the intradermal method. However, skin tests using a
control solution (e.g., saline) were not routinely conducted
with the AST. Skin tests with saline were performed as a
negative control in only two hospitals (F and G, Table 2),
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Table 1. Types and concentrations of antibiotics tested in 12 hospitals
Hospitals Penicillin G, Semisynthetic Cephalosporin, Carbapenem, Vancomycin, Streptomycin, Monobactam,
IU/mL penicillin, mg/mL mg/mL mg/mL mg/mL mg/mL mg/mL
A 1 / 100a 1 / 100a 1 / 100a 1 / 100a ND 1 / 100a ND
B 1 / 100a 1 / 100a 1 / 100a 1 / 100a 1 / 100a ND ND
C 500 0.3 0.3 0.3 ND 0.1 ND
D 800 0.3 0.3 ND ND ND ND
E 10,000 3 ND 1 ND ND 3
F 5 1 1 ND ND ND ND
G 1,500 0.3 0.3 0.3 ND ND ND
HN D N D 2 0 2 02 0 N D N D
I No use 0.1 0.1 ND 0.1 ND ND
Jb 10,000 3 4 4 ND 4 ND
Kb 50,000 5 5 5 5 ND ND
Lb 10,000 3 4 4 ND ND ND
ND, not done.
a1 / 100 dilution regardless of the antibiotic type and dose. 
bSecondary hospitals; the others are tertiary hospitals.following the AST and for suspicious, false-positive results
cases. The injection amounts varied among the hospitals,
ranging from 0.02 to 0.3 mL (Table 2). The concentrations
tested also varied among hospitals (Table 1). For example,
testing concentrations for penicillin G showed a 10,000
fold difference, ranging from 5 IU/mL to 50,000 IU/mL.
However, the time lag (15 to 20 minutes) between testing
and interpretation was similar in all hospitals. The criteria
for positive results on the AST varied and were inconsistent
among the hospitals: either a wheal or erythema larger
than standard in six hospitals, only a wheal regardless of
erythema in four hospitals, and only erythema in one
hospital. Only one hospital considered both a wheal and
erythema for interpreting the results. Additionally, the
wheal and erythema standards for a positive response
varied among the hospitals (Table 2). 
DISCUSSION
We examined the current practice of AST in 12 Korean
general hospitals with different grades and locations. We
emphasize that what we examined in this study was the
routine testing performed for screening in all patients in
general wards and not what allergy specialists do.
Unexpectedly, the AST protocols varied from hospital to
hospital with regard to the types of antibiotics tested,
testing concentrations and amounts, and the interpretation
method. Therefore, discussing the similarities and
differences between the current practices and the
commonly recommended procedures in the medical
literature is warranted.
AST methods
Some experts recommend that the general method for
the AST is an intradermal test after confirming a negative
skin prick test [8-10]. Intradermal testing is performed on
the volar surface of the forearm with a 0.02 to 0.05 mL
injection of the reagent solution, raising a 3 mm wheal,
with saline as the negative control and with histamine as
the positive control [8-10]. Similarly, all hospitals enrolled
in the present study conducted AST using intradermal
methods. Because the AST protocol in this study was the
practice performed in wards, only intradermal testing was
performed. However, intradermal testing was performed
without any control, which makes the interpretation of
the test results more difficult and increases the likelihood
of a false-negative or false-positive result. Moreover, the
volumes injected varied from one to ten times more than
the volume recommended in the medical literature.
Although the intradermal test is thought to be relatively
safe, it may induce severe reactions, such as anaphylaxis,
especially when a large volume is injected. Considering
this, AST should be performed using the proper volume of
antibiotics.
The antibiotic concentrations tested should not cause
any significant irritation in subjects with good tolerance to
antibiotics. Currently, the maximum concentrations used
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Table 2. Injection volume and interpretation of antibiotic skin testing in 12 Korean hospitals
Hospitals Injection amount, mL Reading
After administration, min Positive result
A Make a bleb, 5 - 10 mm  15 - 20 W > 10 mm or E > 15 mm
B 0.2 - 0.3 15 W > 5 mm
C 0.02 15 W > initial
D 0.02 15 - 20 W > 10 mm or E > 15 mm
E 0.02 15 - 20 W > 4 mm and E (+)
F 0.1 15 - 20 E > 10 mm
G Make a bleb, 3 mm  15 - 20 W > 1.5 times
H 0.02 15 - 20 W > initial or E (+)
I Make a bleb, 3 mm 15 W > initial
Ja 0.1 15 - 20 W > 10 mm or E > 15 mm
Ka 0.1 15 W > initial or E (+)
La 0.1 15 - 20 W >10 mm or E > 10 mm
W, wheal; E, erythema. 
aSecondary hospitals; the others are tertiary hospitals.differ from the accepted guidelines recommended by the
American Academy of Allergy, Asthma and Immunology
(AAAAI) / Joint Council of Allergy Asthma and Immunology
(JCAAI) [8], the European Network for Drug Allergy
(ENDA) / European Academy of Allergy, and the
European Academy of Allergy and Clinical Immunology
(EAACI) [9,10], as shown in Table 3. Notably, the testing
concentrations in the hospitals we studied varied widely
from one-thousandth less to ten times more than those
recommended by published guidelines [8-10]. This is an
important issue because testing with too low an antibiotic
concentration can result in a false-negative, and too high a
concentration can cause irritation and a false-positive
result. Furthermore, high concentrations of antibiotics
elevate the risk for anaphylaxis. 
AST interpretation
Interpretation is recommended 15 to 20 minutes after
the injection [3,8-10]. For the intradermal test, the wheal
area should be marked initially and again 15 to 20 minutes
later, and an increase in the diameter greater than 3 mm is
considered positive [3,8-10]. As mentioned above, we
found that the criteria for a positive result varied too much
and were inconsistent among the hospitals, although the
time lag between test and interpretation was similar (15 to
20 minutes). These inconsistencies made a comparison of
test results among hospitals difficult.
Selection of antibiotics tested
AST is recommended as a routine practice for patients
with suspected immediate-type allergy to penicillins
(including semisynthetic penicillins) and cephalosporins
but not to other antibiotics [11-16]. The proportion of
patients labeled as allergic to penicillin who have a true
IgE-medicated reaction to penicillin is very low [8,17,18].
Among these patients, over 80% have negative skin test
results and no allergic reaction if challenged, whereas
most patients with positive skin test results will react if
challenged [19]. Penicillin skin testing has a high negative
predictive value and is reliable for identifying individuals
at risk for an immediate allergic reaction to penicillins
[11,20,21]. Recent studies have shown that using the
penicillin skin test helps determine an appropriate
antibiotic treatment for patients with a history of penicillin
allergy and reduces the use of broad-spectrum antibiotics,
which may be a useful strategy for managing antibiotic
resistance [11,19,22,23]. Many patients with a history of
penicillin allergy and positive penicillin skin test results
have a vague history of a prior reaction to penicillin [24].
In other words, the patient history may not be accurate,
and penicillin skin testing should be considered for
confirmation. 
The increased use of beta-lactam antibiotics other
then penicillin, such as amoxicillin, ampicillin, and
cephalosporins, has increased the chance for allergic
reactions to these antibiotics; thus, evaluating primary
sensitization and cross-reactivities is important. The AST
value for semisynthetic penicillins has been assessed
extensively [10,25-27]. Semisynthetic penicillins may
induce specific reactions and skin test positivity without
cross-reacting to penicillins, which makes it necessary to
include semisynthetic penicillins in ASTs. However, the
negative predictive value of skin testing is unknown for
cephalosporins [15,28]. Previous studies have reported
a high negative predictive value when using parent
cephalosporins at 2 mg/mL, but further study is needed
for confirmation [16,29]. Moreover, cross-reactivity infor-
mation between penicillins and cephalosporins is lacking.
Considering a 4.4% rate of cross-reaction to cephalosporins
in patients with a history of penicillin allergy and a
positive result on a penicillin skin test [30], cephalosporin
skin testing should be performed in patients with a history
of penicillin allergy. The AST is not only a relatively simple
and safe procedure but also a minimally required procedure
to avoid medical / legal problems. 
The usefulness of skin testing for carbapenems has not
been determined. Moreover, the cross-reactivity between
penicillins and carbapenems is unclear, as studies have
reported conflicting findings [21,31-35]. Recently,
Romano et al. [35] published two prospective studies on
the utility of skin testing to detect immediate-type allergic
reactions to imipenem-cilastatin and meropenem [36].
Because skin testing with an unmetabolized drug is
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Table 3. Beta-lactam concentrations recommended for
skin testing 
Hapten USAa Europeb
Penicillin G, IU/mL 10,000 10,000
PPL, mmol/L 6 × 10-5 6 × 10-6
MDM, mmol/L 10-2 2 × 10-2
Cephalosporin, mg/mL 2 - 3 2
Semisynthetic penicillinc, mg/mL - 20
PPL, penicilloyl-polylysine; MDM, minor determinant mixture.
aAdopted from reference [8].
bAdopted from references [9,10].
cAmpicillin, amoxicillin, and piperacillin.unlikely to detect all sensitive individuals, patients with a
negative reaction underwent a graded challenge, and no
patients reacted. The authors concluded that this approach
appeared safe, that the cross-reactivity was better defined,
and that carbapenem reagents for skin testing are
available. However, further confirmation is needed.
Many hospitals enrolled in the present study performed
ASTs with antibiotics such as vancomycin, streptomycin,
and monobactam that have not yet been validated. Up to
five different antibiotics were identified in six hospitals (A,
B, C, E, J, and K, Table 1). An AST should be performed to
identify immediate-type allergic reactions to penicillins
and cephalosporins, as discussed above, and not to other
antibiotics in which the reliability of AST has not been
validated. 
This inconsistency in the AST procedure can result in a
waste of time, money, labor, and the nation’s resources
and can put patients at risk. Moreover, inconsistencies in
the AST procedure make it difficult to conduct comparative
studies on adverse antibiotic events among countries and
hospitals. Of course, we should not accept other countries
guidelines blindly but make our guidelines adequate for
our circumstances. In conclusion, the practice of AST
performed in hospital wards in Korea was too varied and
inconsistent. The standardized guidelines for AST must be
followed for the safe and effective use of antibiotics in
Korea.
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